Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Neko Health raises $700 million to bring full-body scan clinics to the US

Neko Health raises $700 million to bring full-body scan clinics to the US

Money Moves

Daniel Ek's preventive-care startup hits a roughly $7 billion valuation and plans its first American clinic in New York

Yesterday: Neko raises $700 million for US launch

Overview

Neko Health just raised $700 million, one of the largest single funding rounds the preventive-health field has seen. The Swedish company, co-founded by Spotify's Daniel Ek, will use the money to open its first US clinic in New York.

Neko sells a 60-minute full-body scan meant to catch disease before symptoms appear. More than 100,000 people have been scanned in Sweden and the UK, and over 300,000 more are on a US waitlist. The round values the company at about $7 billion, roughly four times its worth 18 months ago.

Why it matters

If Neko's model works, catching disease early could shift from a doctor's referral to a $300 scan you book like a dentist appointment.

Questions about this story

No questions yet — be the first to ask.

Key Indicators

$700M
Series C raised
Led by Lightspeed Venture Partners, co-led by O.G. Venture Partners.
~$7B
Valuation
About four times the roughly $1.8 billion valuation set in January 2025.
100,000+
People scanned
Across six clinics in Sweden and the UK since 2023.
300,000+
US waitlist
Sign-ups waiting for the first American clinic to open.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Play

Exploring all sides of a story is often best achieved with Play.

Log in to play. Track your picks, climb the leaderboards. Log in Sign Up
Predict 3 ways this could play out. Contrarian picks score more — points lock when the scenario resolves. Log in to play
Higher or Lower Two numbers from this story. Guess which is bigger. 5 rounds to set a streak. Log in to play
Connections Sixteen names from the news. Find the four hidden groups of four. Log in to play

People Involved

Organizations Involved

Timeline

January 2018 July 2026

4 events Latest: Yesterday
Tap a bar to jump to that date
  1. Neko raises $700 million for US launch

    Latest Funding

    The Series C values Neko near $7 billion and funds its first US clinic in New York.

  2. Series B raises $260 million

    Funding

    The round values Neko at roughly $1.8 billion as it expands into the UK.

  3. First clinic opens in Stockholm

    Milestone

    Neko begins offering its 60-minute full-body scan to the public in Sweden.

  4. Neko Health founded

    Founding

    Daniel Ek and Hjalmar Nilsonne start Neko to catch disease before symptoms appear.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

2015-2018

Theranos collapse (2018)

Theranos claimed its machines could run hundreds of tests from a single drop of blood. Investigations found the technology did not work as promised. Founder Elizabeth Holmes was later convicted of fraud.

Then

The company dissolved in 2018 and investors lost roughly $700 million.

Now

It made investors and regulators far more skeptical of health startups that promise breakthrough diagnostics without published evidence.

Why this matters now

Neko sells consumer diagnostics on a bold promise too. The Theranos memory raises the bar for proof that its scans actually improve health outcomes.

2007-2025

23andMe rise and fall (2007-2025)

23andMe sold at-home DNA kits that gave consumers health and ancestry data. It reached a multibillion-dollar valuation, then struggled to turn one-time tests into lasting revenue and filed for bankruptcy in 2025.

Then

The company's value collapsed from a peak near $6 billion.

Now

It showed that consumer health data is easy to sell once but hard to build a durable business around.

Why this matters now

Neko faces the same question: can a one-time scan become a repeat relationship, or will customers scan once and not return?

2024-2026

Whole-body MRI screening debate (2024-2026)

US firms like Prenuvo and Ezra scanned tens of thousands of healthy people with MRI. Medical reviews warned of frequent false positives and no proven survival benefit, while the companies defended the scans' value.

Then

The companies kept growing despite the criticism.

Now

The dispute over screening healthy people remains unsettled, with no clear regulatory ruling.

Why this matters now

Neko enters a US market already arguing about whether scanning the healthy helps or harms. It will inherit that debate on day one.

Sources

(6)